Global Drug Discovery Screening Service Supply, Demand and Key Producers, 2023-2029

Global Drug Discovery Screening Service Supply, Demand and Key Producers, 2023-2029

The global Drug Discovery Screening Service market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Drug screening refers to the process of using appropriate methods to evaluate the biological activity, pharmacological effects and medicinal value of substances (samples) that may be used as drugs. Drug screening is a key step in the development of new drugs.

This report studies the global Drug Discovery Screening Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Drug Discovery Screening Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Discovery Screening Service that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Drug Discovery Screening Service total market, 2018-2029, (USD Million)

Global Drug Discovery Screening Service total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Drug Discovery Screening Service total market, key domestic companies and share, (USD Million)

Global Drug Discovery Screening Service revenue by player and market share 2018-2023, (USD Million)

Global Drug Discovery Screening Service total market by Type, CAGR, 2018-2029, (USD Million)

Global Drug Discovery Screening Service total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Drug Discovery Screening Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River Laboratories, Evotec, TargetMol, Abeomics, DefiniGEN, Multispan, MIMETAS, Melior Discovery and Thermo Fisher, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug Discovery Screening Service market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Drug Discovery Screening Service Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Drug Discovery Screening Service Market, Segmentation by Type
Phenotypic Screening
Target Screening

Global Drug Discovery Screening Service Market, Segmentation by Application
Pharmaceutical Company
Research Institute
Others

Companies Profiled:
Charles River Laboratories
Evotec
TargetMol
Abeomics
DefiniGEN
Multispan
MIMETAS
Melior Discovery
Thermo Fisher
Eurofins Discovery
Horizon Discovery
Crown Bioscience
Pharmaron
Beijing Abace Biotechnology
Viva Biotech Holdings
HD Biosciences
SAFE Pharmaceutical Technology
Shanghai Medicilon

Key Questions Answered

1. How big is the global Drug Discovery Screening Service market?

2. What is the demand of the global Drug Discovery Screening Service market?

3. What is the year over year growth of the global Drug Discovery Screening Service market?

4. What is the total value of the global Drug Discovery Screening Service market?

5. Who are the major players in the global Drug Discovery Screening Service market?